Bharat Biotech is recently producing the vaccine for a phase 1 human protection and immunogenicity study, which is expected to begin in the coming months. The Bharat Biotech-Jefferson collaboration announced on May 20.
Bharat Biotech is recently producing the vaccine for a phase 1 human protection and immunogenicity study, which is expected to begin in the coming months. The Bharat Biotech-Jefferson collaboration announced on May 20.